| abstract |
It is a hepatocyte growth factor (HGF) receptor, has tyrosine kinase activity, inhibits the signal pathway of c-Met protein, which is a transmembrane 190 kDa heterodimer, and is useful for cancer treatment Novel compounds and pharmaceutical compositions containing the compounds. A specific triazolopyridine compound and / or triazolopyrazine compound represented by a compound represented by the following formula 1 and a pharmaceutical composition containing the compound and useful for the treatment of cancer. [Selection figure] None |